📰 Nasdaq Impl News
Nasdaq Impl News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Impl. Real-time updates on events, politics, business and more.
November 25, 2023
Impel Pharmaceuticals (NASDAQ:IMPL – Get Free Report) and Antibe Therapeutics (OTCMKTS:ATBPF – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Impel […]
September 19, 2023
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 505,100 shares, a drop of 12.7% from the August 15th total of 578,800 shares. Currently, 6.5% of the company’s stock are short sold. Based on an average daily volume […]
June 8, 2023
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating)’s stock price dropped 7.6% during trading on Monday . The company traded as low as $1.22 and last traded at $1.22. Approximately 20,793 shares changed hands during trading, a decline of 59% from the average daily volume of 50,243 shares. The stock had previously closed at $1.32. Impel […]
May 16, 2023
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Approximately 5.5% of the shares of the stock are short sold. Based on […]
May 16, 2023
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Based on an average trading volume of 46,600 shares, the days-to-cover ratio is […]
May 6, 2023
Impel Pharmaceuticals (NASDAQ:IMPL – Get Rating) is scheduled to release its earnings data before the market opens on Friday, May 12th. Impel Pharmaceuticals Stock Up 12.6 % NASDAQ IMPL opened at $2.60 on Friday. The company has a market capitalization of $61.75 million, a P/E ratio of -0.57 and a beta of -0.26. Impel Pharmaceuticals […]
May 2, 2023
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 389,700 shares, a growth of 17.1% from the March 31st total of 332,800 shares. Based on an average daily trading volume, of 42,800 shares, […]
May 1, 2023
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 389,700 shares, a growth of 17.1% from the March 31st total of 332,800 shares. Currently, 5.1% of the company’s shares are sold short. Based on an average […]
April 26, 2023
New Analysis Indicates No Drug-Drug Interactions (DDIs) of Clinical Concern are Predicted When Recommended Doses of Trudhesa and Gepants are...
April 26, 2023
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating)’s share price dropped 2.8% during trading on Monday . The stock traded as low as $1.74 and last traded at $1.77. Approximately 10,438 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 41,313 shares. The stock had previously closed at $1.82. […]